4.2.5 Emerging therapies
Emerging therapies showing promise for treating ovarian cancer include DNA-damaged pathway inhibitors. Other therapies may be considered within the confines of a clinical trial.
Immunotherapy has not been shown to be of benefit and should not be used outside of a clinical trial.